116 related articles for article (PubMed ID: 38342251)
21. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
[TBL] [Abstract][Full Text] [Related]
23. Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients.
Miyasaka T; Yamada T; Uehara K; Sonoda H; Matsuda A; Shinji S; Ohta R; Kuriyama S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kanaka S; Ohashi R; Yoshida H
Cancer Sci; 2024 Apr; 115(4):1184-1195. PubMed ID: 38297479
[TBL] [Abstract][Full Text] [Related]
24. TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers.
Golozar M; Motlagh AV; Mahdevar M; Peymani M; InanlooRahatloo K; Ghaedi K
Exp Mol Pathol; 2024 Apr; 136():104890. PubMed ID: 38378070
[TBL] [Abstract][Full Text] [Related]
25. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of genes associated with poor prognosis of patients with colorectal cancer liver metastasis.
Qian Z; Zhang G; Song G; Shi J; Gong L; Mou Y; Han Y
Oncotarget; 2017 Apr; 8(15):25500-25512. PubMed ID: 28424419
[TBL] [Abstract][Full Text] [Related]
27. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
28. Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation.
Hosseini ST; Nemati F
Sci Rep; 2023 Oct; 13(1):17086. PubMed ID: 37816854
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
Wu SM; Tsai WS; Chiang SF; Lai YH; Ma CP; Wang JH; Lin J; Lu PS; Yang CY; Tan BC; Liu H
Sci Rep; 2020 Mar; 10(1):4526. PubMed ID: 32161294
[TBL] [Abstract][Full Text] [Related]
30. Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis.
Cui C; Zhang R; Gu F; Pei Y; Sun L; Huang Y; Niu G; Li J
J Immunol Res; 2022; 2022():1336509. PubMed ID: 35664357
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.
Li R; Zhou R; Wang H; Li W; Pan M; Yao X; Zhan W; Yang S; Xu L; Ding Y; Zhao L
Cell Death Differ; 2019 Nov; 26(11):2447-2463. PubMed ID: 30850734
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
Chen J; Wang Z; Shen X; Cui X; Guo Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
[TBL] [Abstract][Full Text] [Related]
33. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
34. Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database.
Wang G; Wang F; Meng Z; Wang N; Zhou C; Zhang J; Zhao L; Wang G; Shan B
BMC Cancer; 2022 Feb; 22(1):138. PubMed ID: 35114976
[TBL] [Abstract][Full Text] [Related]
35. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
[TBL] [Abstract][Full Text] [Related]
36. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
[TBL] [Abstract][Full Text] [Related]
37. Identification of four novel hub genes as monitoring biomarkers for colorectal cancer.
Luo D; Yang J; Liu J; Yong X; Wang Z
Hereditas; 2022 Jan; 159(1):11. PubMed ID: 35093172
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
39. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
40. FJX1 as a candidate diagnostic and prognostic serum biomarker for colorectal cancer.
Liu L; Huang Y; Li Y; Wang Q; Hao Y; Liu L; Yao X; Yao X; Wei Y; Sun X; Guo Y
Clin Transl Oncol; 2022 Oct; 24(10):1964-1974. PubMed ID: 35650386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]